Reduced brain edema and functional deficits after treatment of diffuse traumatic brain injury by carbamylated erythropoietin derivative

Critical Care Medicine

Volumn 39, Issue 9, 2011, Pages 2099-2105

  Bouzat, Pierre ^a,b   Francony, Gilles ^a,b   Thomas, Sébastien ^a,b   Valable, Samuel ^c   Mauconduit, Franck ^a   Fevre, Marie Cécile ^a,b   Barbier, Emmanuel L ^a   Bernaudin, Myriam ^c   Lahrech, Hana ^a   Payen, Jean Francois ^a,b  

^a GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^b HÔPITAL MICHALLON   (France)

^c UNIVERSITÉ DE CAEN   (France)

Author keywords

brain edema; carbamylated erythropoietin; erythropoietin; magnetic resonance diffusion weighted imaging; magnetic resonance imaging; neurological outcome; traumatic brain injury

Indexed keywords

CARBAMYLATED ERYTHROPOIETIN DERIVATIVE; ERYTHROPOIETIN; MITOGEN ACTIVATED PROTEIN KINASE 1; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EDEMA; CARBAMOYLATION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DIFFUSE TRAUMATIC BRAIN INJURY; DIFFUSION WEIGHTED IMAGING; DRUG EFFECT; MALE; MOTOR PERFORMANCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REFLEX; SHAM PROCEDURE; SIGNAL TRANSDUCTION; SOMATOMOTOR REFLEX; TRAUMATIC BRAIN INJURY;

EID: 80051950683     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31821cb7b2     Document Type: Article

References (40)

1. Gassmann M, Heinicke K, Soliz J, et al: Nonerythroid functions of erythropoietin. Adv Exp Med Biol 2003; 543:323-330
2. Brines M, Cerami A: Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 2005; 6:484-494 (Pubitemid 40769173)
3. Velly L, Pellegrini L, Guillet B, et al: Erythropoietin 2nd cerebral protection after acute injuries: A double-edged sword? Pharmacol Ther 2010; 128:445-459
4. Ehrenreich H, Weissenborn K, Prange H, et al: Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 2009; 40:e647-e656
5. Lapchak PA: Carbamylated erythropoietin to treat neuronal injury: New development strategies. Expert Opin Investig Drugs 2008; 17:1175-1186
6. Leist M, Ghezzi P, Grasso G, et al: Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 2004; 305: 239-242 (Pubitemid 38886736)
7. Kirkeby A, Torup L, Bochsen L, et al: Highdose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO). Thromb Haemost 2008; 99:720-728 (Pubitemid 351694228)
8. Villa P, van Beek J, Larsen AK, et al: Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives. J Cereb Blood Flow Metab 2007; 27:552-563
9. Wang Y, Zhang ZG, Rhodes K, et al: Postischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia. Br J Pharmacol 2007; 151:1377-1384 (Pubitemid 47255890)
10. King VR, Averill SA, Hewazy D, et al: Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat. Eur J Neurosci 2007; 26:90-100 (Pubitemid 47035440)
11. Lapchak PA, Kirkeby A, Zivin JA, et al: Therapeutic window for nonerythropoietic carbamylated-erythropoietin to improve motor function following multiple infarct ischemic strokes in New Zealand white rabbits. Brain Res 2008; 1238:208-214
12. Mahmood A, Lu D, Qu C, et al: Treatment of traumatic brain injury in rats with erythropoietin and carbamylated erythropoietin. J Neurosurg 2007; 107:392-397 (Pubitemid 47219384)
13. Adembri C, Massagrande A, Tani A, et al: Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury. Crit Care Med 2008; 36: 975-978
14. Xiong Y, Mahmood A, Zhang Y, et al: Effects of posttraumatic carbamylated erythropoietin therapy on reducing lesion volume and hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome in rats following traumatic brain injury. J Neurosurg 2011; 114:549-559
15. Unterberg AW, Stover J, Kress B, et al: Edema and brain trauma. Neuroscience 2004; 129:1021-1029 (Pubitemid 39556253)
16. Vink R, Nimmo AJ: Multifunctional drugs for head injury. Neurotherapeutics 2009; 6:28-42
17. Francony G, Fauvage B, Falcon D, et al: Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med 2008; 36: 795-800
18. Verdonck O, Lahrech H, Francony G, et al: Erythropoietin protects from post-traumatic edema in the rat brain. J Cereb Blood Flow Metab 2007; 27:1369-1376 (Pubitemid 46985353)
19. Valable S, Francony G, Bouzat P, et al: The impact of erythropoietin on short-term changes in phosphorylation of brain protein kinases in a rat model of traumatic brain injury. J Cereb Blood Flow Metab 2010; 30: 361-369
20. Mori T, Wang X, Jung JC, et al: Mitogenactivated protein kinase inhibition in traumatic brain injury: In vitro and in vivo effects. J Cereb Blood Flow Metab 2002; 22: 444-452 (Pubitemid 34273600)
21. Otani N, Nawashiro H, Fukui S, et al: Role of the activated extracellular signal-regulated kinase pathway on histological and behavioral outcome after traumatic brain injury in rats. J Clin Neurosci 2007; 14:42-48 (Pubitemid 44809930)
22. Marmarou A, Foda MA, van den Brink W, et al: A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. J Neurosurg 1994; 80:291-300 (Pubitemid 24036501)
23. Beaumont A, Marmarou A, Czigner A, et al: The impact-acceleration model of head injury: Injury severity predicts motor and cognitive performance after trauma. Neurol Res 1999; 21:742-754
24. Freret T, Valable S, Chazalviel L, et al: Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat. Eur J Neurosci 2006; 23: 1757-1765
25. Lukoyanov NV, Lukoyanova EA: Retrosplenial cortex lesions impair acquisition of active avoidance while sparing fear-based emotional memory. Behav Brain Res 2006; 173:229-236 (Pubitemid 44308499)
26. Beaumont A, Marmarou A, Hayasaki K, et al: The permissive nature of blood brain barrier (BBB) opening in edema formation following traumatic brain injury. Acta Neurochir Suppl 2000; 76:125-129
27. Beaumont A, Fatouros P, Gennarelli T, et al: Bolus tracer delivery measured by MRI confirms edema without blood-brain barrier permeability in diffuse traumatic brain injury. Acta Neurochir Suppl 2006; 96:171-174
28. Barzó P, Marmarou A, Fatouros P, et al: Contribution of vasogenic and cellular edema to traumatic brain swelling measured by diffusion-weighted imaging. J Neurosurg 1997; 87:900-907 (Pubitemid 27508597)
29. Huisman TA: Diffusion-weighted imaging: Basic concepts and application in cerebral stroke and head trauma. Eur Radiol 2003; 13:2283-2297 (Pubitemid 37220363)
30. Frei HJ, Wallenfang T, Pö ll W, et al: Regional cerebral blood flow and regional metabolism in cold induced oedema. Acta Neurochir (Wien) 1973; 29:15-28
31. Brines ML, Ghezzi P, Keenan S, et al: Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 2000; 97: 10526-10531
32. Montero M, Poulsen FR, Noraberg J, et al: Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures. Exp Neurol 2007; 204:106-117 (Pubitemid 46330263)
33. Jayakumar AR, Rao KV, Panickar KS, et al: Trauma-induced cell swelling in cultured astrocytes. J Neuropathol Exp Neurol 2008; 67:417-427 (Pubitemid 351653534)
34. Huang H, Fan S, Ji X, et al: Recombinant human erythropoietin protects against experimental spinal cord trauma injury by regulating expression of the proteins MKP-1 and p-ERK. J Int Med Res 2009; 37:511-519
35. Rao KV, Jayakumar AR, Reddy PV, et al: Aquaporin-4 in manganese-treated cultured astrocytes. Glia 2010; 58:1490-1499
36. Foda MA, Marmarou A: A new model of diffuse brain injury in rats. Part II: Morphological characterization. J Neurosurg 1994; 80: 301-313 (Pubitemid 24036502)
37. Grasso G, Sfacteria A, Meli F, et al: Neuroprotection by erythropoietin administration after experimental traumatic brain injury. Brain Res 2007; 1182:99-105 (Pubitemid 350086993)
38. Shein NA, Grigoriadis N, Alexandrovich AG, et al: Differential neuroprotective properties of endogenous and exogenous erythropoietin in a mouse model of traumatic brain injury. J Neurotrauma 2008; 25:112-123 (Pubitemid 351252576)
39. Homsi S, Federico F, Croci N, et al: Minocycline effects on cerebral edema: Relations with inflammatory and oxidative stress markers following traumatic brain injury in mice. Brain Res 2009; 1291:122-132
40. Cutler SM, Cekic M, Miller DM, et al: Progesterone improves acute recovery after traumatic brain injury in the aged rat. J Neurotrauma 2007; 24:1475-1486 (Pubitemid 47493512)